Diabetes and Sleep Apnoea

Type 2 diabetes and obstructive sleep apnoea (oSa) are diseases with high prevalence and major public health impact. There is evidence that oSa is independently associated with alterations in glucose metabolism. Furthermore, oSa is a significant risk factor for the development of type 2 diabetes. Possible causes might be intermittent hypoxaemia and sleep fragmentation with increased oxidative stress and sympathetic activity, which are typical features of oSa. oSa might also be a reason for ineffective treatment of type 2 diabetes. There is further evidence that the treatment of oSa by continuous positive airway pressure (cPaP) therapy might improve glucose metabolism. on the other hand, there are also hints in the literature that type 2 diabetes might induce sleep apnoea, especially in patients with autonomic neuropathy, but that oSa also facilitates the development of neuropathy in terms of mutual interactions between oSa, type 2 diabetes and diabetic neuropathy. Based on the current scientific data, clinicians have to be aware of the relations between oSa and type 2 diabetes, both from the sleep medical and the diabetological point of view.